Related Experiment Videos
Neuropathy accompanying IgM lambda monoclonal gammopathy
Acta Neuropathologica
|January 1, 1983
Summary
This study links IgM lambda monoclonal gammopathy to neuropathy by showing patient antibodies target myelin-associated glycoprotein. This suggests an autoimmune basis for the nerve damage in this condition.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Monoclonal gammopathies can be associated with neurological disorders.
- The role of humoral immunity in neuropathy pathogenesis requires further elucidation.
Observation:
- A patient with IgM lambda monoclonal gammopathy and neuropathy exhibited increased intraperiod lines in sural nerve biopsy.
- Deposits of mu-heavy and lambda-light chains were identified within the myelin sheaths.
Findings:
- Patient's serum antibodies (mu-heavy and lambda-light chains) bound to peripheral nerve myelin sheaths and CNS myelin.
- Immunoblotting confirmed specific binding to myelin-associated glycoprotein (MAG) by these antibodies.
- Other immunoglobulin isotypes also bound MAG, but less distinctly than mu and lambda chains.
Implications:
- Humoral immunity, specifically antibodies against MAG, is implicated in the neuropathy associated with IgM lambda monoclonal gammopathy.
- The monoclonal gammopathy may arise secondary to a polyclonal autoimmune response targeting MAG.
- This finding opens avenues for targeted immunotherapies in related neuropathies.